EPCAM and hepatocellular carcinoma: To assess the diagnostic potential of MRT‐dPCR testing and traditional CTC identification methods for HCC, concurrent MRT‐dPCR assays and immunofluorescence (IF) identification targeting the EpCAM marker on MRX‐CTC chips were subsequently conducted on 15 HD samples and 26 HCC samples.